The Impact of Age and Time Since Diagnosis on Response to Treatment with Secukinumab in Pooled Week 52 Data from 4 Phase 3 Studies in Patients with Ankylosing Spondylitis

被引：0
|
作者：
Deodhar, Atul
Mease, Philip
Machado, Paula
Pournara, Effie
Meng, Xiangyi
Strand, Vibeke
Magrey, Marina
机构：
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
EFFICACY; SAFETY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0350
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies
    Wei, James C. -C.
    Baeten, Dominique
    Sieper, Joachim
    Deodhar, Atul
    Bhosekar, Vaishali
    Martin, Ruvie
    Porter, Brian
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (05) : 589 - 596
  • [2] Impact of Age and Disease Duration on the Response to IL-17A Inhibitor (Secukinumab) Treatment in Ankylosing Spondylitis: Pooled Results from the Phase 3 MEASURE Studies
    Deodhar, Atul
    Mease, Philip
    Machado, Paula
    Meng, Xiangyi
    Strand, Vibeke
    Magrey, Marina
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] SECUKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITIS, IRRESPECTIVE OF TIME SINCE FIRST DIAGNOSIS: POOLED RESULTS FROM THE SECUKINUMAB PHASE 3 TRIAL PROGRAM
    Deodhar, Atul
    Boonen, Annelies
    Ferraccioli, Gianfranco
    van den Bosch, Filip
    Martinez, David
    Porter, Brian
    Shete, Abhijit
    Gilloteau, Isabelle
    Yocolly, Aurore
    Strand, Vibeke
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 878 - 879
  • [4] Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies
    Deodhar, Atul A.
    Miceli-Richard, Corine
    Baraliakos, Xenofon
    Marzo-Ortega, Helena
    Gladman, Dafna D.
    Blanco, Ricardo
    Das Gupta, Ayan
    Martin, Ruvie
    Safi, Jorge
    Porter, Brian
    Shete, Abhijit
    Rosenbaum, James T.
    ACR OPEN RHEUMATOLOGY, 2020, 2 (05) : 294 - 299
  • [5] Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies (vol 20, pg 589, 2017)
    Wei, J. C. C.
    Baeten, D.
    Sieper, J.
    Deodhar, A.
    Bhosekar, V
    Martin, R.
    Porter, B.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (07) : 911 - 911
  • [6] Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies
    Braun, Juergen
    Deodhar, Atul
    Landewe, Robert
    Baraliakos, Xenofon
    Miceli-Richard, Corinne
    Sieper, Joachim
    Quebe-Fehling, Erhard
    Martin, Ruvie
    Porter, Brian
    Gandhi, Kunal K.
    van der Heijde, Desiree
    Gallagher, John
    Maity, Niladri
    Pillai, Neeta
    RMD OPEN, 2018, 4 (02):
  • [7] IMPACT OF TIME SINCE DIAGNOSIS, AGE, AND NUMBER OF PRIOR NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON 52-WEEK CLINICAL RESPONSE TO ADALIMUMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Sieper, J.
    Deodhar, A.
    Hojnik, M.
    Zhang, Y.
    Dougados, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 349 - 350
  • [8] Impact of Time Since Diagnosis, Age, and Number of Prior Non-Steroidal Anti-Inflammatory Drugs on 52-Week Clinical Response to Adalimumab in Patients with Ankylosing Spondylitis
    Sieper, Joachim
    Deodhar, Atul A.
    Hojnik, Maja
    Zhang, Ying
    Dougados, Maxime
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [9] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES
    Schett, Georg
    Baraliakos, Xenofon
    van den Bosch, Filip
    Deodhar, Atul
    Gensler, Lianne S.
    Ostergaard, Mikkel
    Agawane, Shital
    Das Gupta, Ayan
    Mpofu, Shephard
    Fox, Todd
    Winseck, Adam
    Shete, Abhijit
    Porter, Brian
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 873 - 874
  • [10] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES
    Barkham, Nick
    Schett, Georg
    Baraliakos, Xenofon
    van den Bosch, Filip
    Deodhar, Atul
    Gensler, Lianne S.
    Ostergaard, Mikkel
    Agawane, Shital
    Gupta, Ayan Das
    Mpofu, Shephard
    Fox, Todd
    Winseck, Adam
    Shete, Abhijit
    Porter, Brian
    RHEUMATOLOGY, 2020, 59
12345